Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 40,000 shares at $14.41 ($574K) on 2023-07-26, disclosed to the SEC on 2023-07-27.
Scheduled sale ($574k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.30 | 20,000 | $286K | 49.8% |
| 2 | $14.41 | 20,000 | $288K | 50.2% |
| Total | $14.36 avg | 40,000 | $574K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |